Pomanda estimates the enterprise value of CORE MEDICA LIMITED at £2.2m based on a Turnover of £3.5m and 0.62x industry multiple (adjusted for size and gross margin).
core medica limitedEstimated Valuation
£3.4m
Pomanda estimates the enterprise value of CORE MEDICA LIMITED at £3.4m based on an EBITDA of £808.1k and a 4.24x industry multiple (adjusted for size and gross margin).
core medica limitedEstimated Valuation
£7.9m
Pomanda estimates the enterprise value of CORE MEDICA LIMITED at £7.9m based on Net Assets of £3.5m and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Core Medica LimitedOverview
Core Medica Limited is a live company located in cheshire, WA16 8GP with a Companies House number of 05443253. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in May 2005, it's largest shareholder is
prime global medical communications limited
with a 100% stake. Core Medica Limited is a mature,
small sized company, Pomanda has estimated its turnover at
£3.5m with
low
growth in recent years.
Pomanda's financial health check has awarded Core Medica Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
3 Strong
3 Regular
4 Weak
Size
annual sales of £3.5m, make it larger than the average company (£2.9m)
£3.5m - Core Medica Limited
£2.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (7.2%)
1% - Core Medica Limited
7.2% - Industry AVG
Production
with a gross margin of 45%, this company has a comparable cost of product (45%)
45% - Core Medica Limited
45% - Industry AVG
Profitability
an operating margin of 23.1% make it more profitable than the average company (5.6%)
23.1% - Core Medica Limited
5.6% - Industry AVG
Employees
with 28 employees, this is above the industry average (23)
28 - Core Medica Limited
23 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Core Medica Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £125.2k, this is equally as efficient (£125.4k)
£125.2k - Core Medica Limited
£125.4k - Industry AVG
Debtor Days
it gets paid by customers after 77 days, this is later than average (56 days)
77 days - Core Medica Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 12 days, this is quicker than average (31 days)
12 days - Core Medica Limited
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Core Medica Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 6 weeks, this is less cash available to meet short term requirements (24 weeks)
6 weeks - Core Medica Limited
24 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 48.3%, this is a similar level of debt than the average (53.3%)
48.3% - Core Medica Limited
53.3% - Industry AVG
CORE MEDICA LIMITED financials
EXPORT
Core Medica Limited's latest turnover from December 2023 is estimated at £3.5 million and the company has net assets of £3.5 million. According to their latest financial statements, we estimate that Core Medica Limited has 28 employees and maintains cash reserves of £381.8 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Nov 2016
Nov 2015
Nov 2014
Nov 2013
Nov 2012
Nov 2011
Nov 2010
Nov 2009
Turnover
3,506,337
2,631,119
6,046,293
3,436,079
1,784,143
897,082
1,311,928
709,885
667,474
2,389,855
1,491,133
3,974,785
1,082,360
1,043,662
Other Income Or Grants
Cost Of Sales
1,930,138
1,494,088
3,493,644
1,531,512
971,480
773,825
856,782
343,234
328,025
1,190,480
734,361
1,926,702
527,144
493,876
Gross Profit
1,576,199
1,137,032
2,552,649
1,904,567
812,663
123,257
455,146
366,651
339,449
1,199,375
756,772
2,048,082
555,216
549,787
Admin Expenses
768,121
469,321
691,885
689,573
429,032
215,545
208,255
298,684
100,686
1,183,682
751,682
2,061,920
520,091
545,638
894,080
Operating Profit
808,078
667,711
1,860,764
1,214,994
383,631
-92,288
246,891
67,967
238,763
15,693
5,090
-13,838
35,125
4,149
-894,080
Interest Payable
Interest Receivable
19,451
28,793
3,163
31
79
212
140
31
14
12
14
3
Pre-Tax Profit
827,529
696,504
1,863,927
1,214,994
383,662
-92,288
246,891
68,046
238,975
15,833
5,121
-13,824
35,136
4,163
-894,077
Tax
-206,882
-132,336
-354,146
-230,864
-68,092
30
-5,145
-13,609
-47,795
-3,325
-1,178
-9,135
-1,165
Profit After Tax
620,647
564,168
1,509,781
984,130
315,570
-92,258
241,746
54,437
191,180
12,508
3,943
-13,824
26,001
2,997
-894,077
Dividends Paid
Retained Profit
620,647
564,168
1,509,781
984,130
315,570
-92,258
241,746
54,437
191,180
12,508
3,943
-13,824
26,001
2,997
-894,077
Employee Costs
1,427,838
716,096
655,213
919,949
572,502
1,480,880
387,793
419,438
Number Of Employees
28
21
53
30
15
8
12
7
15
22
14
37
10
11
EBITDA*
808,078
667,711
1,860,764
1,214,994
383,688
-92,110
246,990
68,057
238,854
15,701
5,090
-13,678
35,359
4,383
-893,846
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Nov 2016
Nov 2015
Nov 2014
Nov 2013
Nov 2012
Nov 2011
Nov 2010
Nov 2009
Tangible Assets
249
427
174
265
356
160
394
628
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
249
427
174
265
356
160
394
628
Stock & work in progress
Trade Debtors
747,070
565,823
1,313,253
382,609
355,845
109,336
186,414
75,828
22,523
176,666
31,966
5,107
3,710
410
Group Debtors
5,299,726
3,465,374
369,275
486
300
16,278
100
100
19,494
Misc Debtors
397,559
209,853
252,252
94,256
56,437
88,193
45,934
125,469
40,849
Cash
381,800
359,190
1,286,128
1,244,413
239,811
145,599
171,847
27,304
36,039
48,802
7,193
5,308
281
4,369
1,189
misc current assets
782
1,198
129
1,513
total current assets
6,826,155
4,600,240
3,220,908
1,721,764
652,393
359,406
404,295
228,701
118,905
225,468
39,159
6,090
6,586
8,208
3,112
total assets
6,826,155
4,600,240
3,220,908
1,721,764
652,393
359,655
404,722
228,875
119,170
225,824
39,159
6,090
6,746
8,602
3,740
Bank overdraft
Bank loan
Trade Creditors
67,547
65,649
13,912
42,522
87,599
68,027
140,447
223,578
44,799
1,088,176
914,019
876,014
860,502
897,272
897,717
Group/Directors Accounts
1,764,230
916,462
239,859
192,795
352,488
541,671
440,511
560,369
661,483
other short term finances
hp & lease commitments
other current liabilities
1,467,428
711,826
625,002
653,994
363,983
217,204
198,753
61,663
84,060
total current liabilities
3,299,205
1,693,937
878,773
889,311
804,070
826,902
779,711
845,610
790,342
1,088,176
914,019
876,014
860,502
897,272
897,717
loans
hp & lease commitments
Accruals and Deferred Income
8,879
11,223
2,310
other liabilities
provisions
total long term liabilities
8,879
11,223
2,310
total liabilities
3,299,205
1,693,937
878,773
889,311
804,070
826,902
779,711
845,610
790,342
1,088,176
914,019
884,893
871,725
899,582
897,717
net assets
3,526,950
2,906,303
2,342,135
832,453
-151,677
-467,247
-374,989
-616,735
-671,172
-862,352
-874,860
-878,803
-864,979
-890,980
-893,977
total shareholders funds
3,526,950
2,906,303
2,342,135
832,453
-151,677
-467,247
-374,989
-616,735
-671,172
-862,352
-874,860
-878,803
-864,979
-890,980
-893,977
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Nov 2016
Nov 2015
Nov 2014
Nov 2013
Nov 2012
Nov 2011
Nov 2010
Nov 2009
Operating Activities
Operating Profit
808,078
667,711
1,860,764
1,214,994
383,631
-92,288
246,891
67,967
238,763
15,693
5,090
-13,838
35,125
4,149
-894,080
Depreciation
57
178
99
90
91
8
160
234
234
234
Amortisation
Tax
-206,882
-132,336
-354,146
-230,864
-68,092
30
-5,145
-13,609
-47,795
-3,325
-1,178
-9,135
-1,165
Stock
Debtors
2,203,305
2,306,270
1,457,429
64,769
198,775
-18,641
31,051
118,531
-93,800
144,700
31,966
-5,107
1,397
3,300
410
Creditors
1,898
51,737
-28,610
-45,077
19,572
-72,420
-83,131
178,779
-1,043,377
174,157
38,005
15,512
-36,770
-445
897,717
Accruals and Deferred Income
755,602
86,824
-28,992
290,011
146,779
18,451
137,090
-22,397
84,060
-8,879
-2,344
8,913
2,310
Deferred Taxes & Provisions
Cash flow from operations
-844,609
-1,632,334
-8,413
1,164,295
283,172
-127,408
264,753
92,299
-674,458
41,833
1,072
4,597
-3,030
1,783
3,461
Investing Activities
capital expenditure
192
-352
1
-364
-862
Change in Investments
cash flow from investments
192
-352
1
-364
-862
Financing Activities
Bank loans
Group/Directors Accounts
847,768
676,603
47,064
-159,693
-189,183
101,160
-119,858
-101,114
661,483
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-99
100
interest
19,451
28,793
3,163
31
79
212
140
31
14
12
14
3
cash flow from financing
867,219
705,396
50,128
-159,693
-189,152
101,160
-119,858
-101,035
661,695
140
31
14
12
14
103
cash and cash equivalents
cash
22,610
-926,938
41,715
1,004,602
94,212
-26,248
144,543
-8,735
-12,763
41,609
1,885
5,027
-4,088
3,180
1,189
overdraft
change in cash
22,610
-926,938
41,715
1,004,602
94,212
-26,248
144,543
-8,735
-12,763
41,609
1,885
5,027
-4,088
3,180
1,189
core medica limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for core medica limited. Get real-time insights into core medica limited's credit score, group structure and payment trends.
Perform a competitor analysis for core medica limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in WA16 area or any other competitors across 12 key performance metrics.
mere house brook street, knutsford, cheshire, WA16 8GP
Bank
-
Legal Advisor
-
core medica limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to core medica limited. Currently there are 2 open charges and 2 have been satisfied in the past.
core medica limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CORE MEDICA LIMITED. This can take several minutes, an email will notify you when this has completed.
core medica limitedCompanies House Filings - See Documents
